Contribution: REGI - Commercialization and exportation
Nexplasmagen incorporée
$50,000.00
600074107
EF 2026-27 · 2026-04-10
Résumé
Marketing strategy: The project aims to increase the sales of a company specializing in designing medical device technology.
Programme
REGI - Commercialization and exportation
Bénéficiaire
Emplacement
Montréal, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
819165614
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Additional Information
Repayable Contribution
Additional Information (French)
Contribution remboursable
Agreement End Date
2027-12-31
Agreement Number
600074107
Agreement Start Date
2026-04-10
Agreement Title
600074107
Agreement Title (French)
600074107
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Number
0
Description
Marketing strategy: The project aims to increase the sales of a company specializing in designing medical device technology.
Description (French)
Stratégie de commercialisation : le projet vise à augmenter les ventes d'une entreprise spécialisée dans la conception de technologies médicales.
Expected Results
Quebec businesses are innovative and growing
Expected Results (French)
Les entreprises du Québec sont innovantes et en croissance
Organization Code
ced-dec
Organization
Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec
Program Name
REGI - Commercialization and exportation
Program Name (French)
CERI - Commercialisation et exportation
Program Purpose
Strengthen the performance of SMEs in improving their market development capacity.
Program Purpose (French)
Renforcer la performance des PME dans l'amélioration de leurs capacités de développement des marchés.
Recipient Business Number
819165614
Recipient City
Montréal
Recipient Country
CA
Recipient Legal Name
Nexplasmagen incorporée
Recipient Postal Code
H4A 2T7
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
012-2026-2027-Q1-00026
